SMAIO (Software, Machines and Adaptative Implants in Orthopaedics – Euronext Growth Paris, ISIN: FR0014005I80 / Ticker: ALSMA ...

NuVasive and orthopedic devicemaker SMAIO mutually decided to end their software co-development efforts, according to a Jan. 27 news release.

GMED's strong synergies from the NuVasive merger and robust performance in the musculoskeletal solutions space bode well for investors.

Ventris Medical received 510(k) clearance for its bone graft containment technology for use in spinal fusion procedures.The ...

The Global MedTech Industry Outlook for 2025 aims to provide insights into the anticipated performance of the MedTech sectors ...

In the third quarter, Globus' proforma musculoskeletal revenues (assuming NuVasive revenue in the year-ago period) improved 5.4%, marking it the fourth consecutive quarter of pro forma ...

CHARLOTTESVILLE, Va., Jan. 14, 2025 /PRNewswire/ -- MicroAire Surgical Instruments, a Marmon Holdings | Berkshire Hathaway company focused on plastic and upper extremity surgery, is pleased to ...

AUDUBON, PA — Globus Medical, Inc. (NYSE: GMED) has reported impressive preliminary unaudited sales results for the fourth quarter and full year ending December 31, 2024. The medical device ...

Introduction The therapeutic use of cells to address medical issues or illnesses is known as cell therapy . Cells or tissues are transplanted i ...

U.S. aging population and lifestyle factors drive demand for spinal surgeries. Advanced graft technologies and strong healthcare reimbursement fuel market.